Ceribell Director Executes $338,792 Stock Sale; Company Posts Regulatory and Operational Updates
Ceribell, Inc. director Josef Parvizi sold 16,714 shares of common stock on February 19, 2026, for $338,792 under a pre-arranged Rule 10b5-1 trading plan. The stock has risen 68% over six months, and InvestingPro analysis indicates the company is trading above its Fair Value. Concurrent corporate developments include FDA Breakthrough Device Designa…